онкология
1857 проекта
breast cancer168leukemia137skin cancer106prostate cancer99colorectal cancer78lung cancer67pancreatic cancer42liver cancer37cervical cancer10bladder cancer10head and neck cancer7
FP7Индивидуална стипендия2010–2012Нидерландия
FGCMOG · Functional genetic characterization of a mouse model of Glioma
FP7Реинтеграция2010–2015Италия
HSC SELF-RENEWAL · Global microRNA profiling of normal and Pbx1-null hematopoietic stem cells and progenitors for the identification of new regulators of the balance between self-renewal and differentiation
FP7Индивидуална стипендия2010–2012Португалия
MITOCANCERSTEM · Role of Mitochondrial Physiology in Tumor Stem Cell Resistance to Chemotherapeutics
FP7Индивидуална стипендия2010–2012Ирландия
ADUKKIPA74 · In Meso Crystallogenesis of GPCR-protein ligand complexes
FP7Индивидуална стипендия2010–2012Дания
TRAFFIC PROTEOMICS · Proteomic analysis of signaling induced by receptor tyrosine kinase endocytosis
FP7Индивидуална стипендия2010–2012Испания
RBM5 · Molecular mechanisms of RBM5-mediated regulation of alternative splicing: impact on cell proliferation and apoptosis
FP7Индивидуална стипендия2010–2012Обединеното кралство
EDCSANTIANDROGENS · Integrative water sampling for the detection and identification of antiandrogenic contaminants in European rivers
FP7Индивидуална стипендия2010–2012Швейцария
STEMCELLSTRESSCHIP · Microfluidic device for high-throughput three-dimensional culture, mechanical stimulation and drug screening of stem cells
FP7Реинтеграция2010–2014Германия
CELL POLARITY · Role of Microtubule Polarity and Polarized Membrane Traffic in Directed Cell Migration
FP7Реинтеграция2010–2014Италия
POLYQ/AR · POLYGLUTAMINE DISEASES: IMPACT OF PROTEIN AND CELL CONTEXT ON NEUROTOXICITY
FP7Реинтеграция2010–2014Испания
TAMIVIVE · Tools and methods for in vivo electroporation
FP7Индивидуална стипендия2010–2012Испания
EPISTEMCLOCK · Regulation of epidermal stem cells by a molecular clock during tissue homeostasis and cancer
FP7Реинтеграция2010–2014Гърция
COMPUT DRUG DESIGN · Targeting the mutated PI3Kα isoform for the development of novel anti-cancer agents
FP7Реинтеграция2010–2014Израел
SENESCENCE CLEARANCE · Mechanisms of immune surveillance of senescent cells
FP7Реинтеграция2010–2014Обединеното кралство
PERRY/MII/TG · Transgenic models of mammalian meiotic exit
FP7Реинтеграция2010–2014Турция
FP2ONCO · ROLE OF PFKFB3 IN THE REGULATION OF THE CELL CYCLE AND TUMORIGENESIS
FP7Реинтеграция2010–2014Израел
AAA+LON · Mechanistic insights into protein degradation by Lon, a AAA+ protease
FP7Реинтеграция2010–2012Кипър
MIVFC · Development of a multichannel in vivo flow cytometer for the dynamic monitoring of circulating cells
FP7Реинтеграция2010–2013Испания
MCCYC · METAL CATALYZED STRATEGIES FOR C-H BOND ACTIVATION AND CYCLOADDITION. SYNTHETIC APPLICATIONS AND DISCOVERY OF NON CONVETIONAL TRANSFORMATIONS
FP7Реинтеграция2010–2014Нидерландия
RNA-DIREC · RNA-DIRECTED EPIGENETIC REMODELLING IN CANCER
FP7Индивидуална стипендия2010–2012Швеция
IGF1RHC · Targeting IGF-1 receptor in liver cancer with focus on its mechanistic role in transcription and its interaction with the cell cycle machinery
FP7Индивидуална стипендия2010–2013Германия
CD14 · Innate and adaptive immune responses to nanocell-based tumor-targeted cancer therapeutics
FP7Реинтеграция2010–2015Чехия
BIOACTIVECPDS · Biologically Active Organic Compounds Interacting with Adenine-binding Proteins
FP7Индивидуална стипендия2010–2012Обединеното кралство
